Freedom Investment Management’s Allstate ALL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,229
Closed -$462K 737
2025
Q1
$462K Sell
2,229
-159
-7% -$31K 0.04% 450
2024
Q4
$460K Buy
2,388
+39
+2% +$7.57K 0.04% 452
2024
Q3
$446K Sell
2,349
-442
-16% -$78.5K 0.04% 468
2024
Q2
$446K Buy
+2,791
New +$466K 0.04% 461
2020
Q2
Sell
-1,708
Closed -$213K 569
2020
Q1
$213K Buy
+1,708
New +$186K 0.02% 610
2019
Q3
Sell
-2,145
Closed -$218K 685
2019
Q2
$218K Sell
2,145
-90
-4% -$8.79K 0.02% 607
2019
Q1
$211K Sell
2,235
-535
-19% -$48.4K 0.02% 619
2018
Q4
$229K Sell
2,770
-788
-22% -$70.8K 0.02% 659
2018
Q3
$359K Buy
3,558
+184
+5% +$17.9K 0.02% 650
2018
Q2
$308K Sell
3,374
-3,974
-54% -$378K 0.02% 746
2018
Q1
$697K Buy
7,348
+406
+6% +$39.3K 0.04% 497
2017
Q4
$727K Buy
6,942
+4,062
+141% +$400K 0.04% 490
2017
Q3
$265K Sell
2,880
-127
-4% -$11.5K 0.01% 905
2017
Q2
$266K Sell
3,007
-75
-2% -$6.36K 0.02% 849
2017
Q1
$251K Buy
3,082
+252
+9% +$19.8K 0.01% 852
2016
Q4
$210K Buy
+2,830
New +$199K 0.01% 880

Other funds holding ALL

Freedom Investment Management's ALL Position: Q2 2025 in Review

Freedom Investment Management sold out of Allstate (ALL) in Q2 2025, closing a stake of 2,229 shares — an estimated $462K sold.

Freedom Investment Management first reported a position in ALL in Q4 2016 and held it in 16 quarters. The position peaked at $727K in Q4 2017. 1,575 funds tracked by Wall St. Rank hold ALL as of Q2 2025.

  • Freedom Investment Management reported no remaining Allstate position as of Q2 2025 after selling out during the quarter.
  • Freedom Investment Management sold 2,229 Allstate shares in Q2 2025, an estimated $462K.
  • Freedom Investment Management first reported a position in Allstate in Q4 2016 and held it in 16 quarters.
  • Freedom Investment Management's Allstate position peaked at $727K in Q4 2017.
  • 1,575 funds tracked by Wall St. Rank held Allstate as of Q2 2025.

Based on Freedom Investment Management's 13F filing for Q2 2025, filed 30 Jul 2025.